BLR

Ducommun Incorporated Reports First Quarter 2024 Results

Retrieved on: 
Mercoledì, Maggio 8, 2024

SANTA ANA, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- Ducommun Incorporated (NYSE: DCO) (“Ducommun” or the “Company”) today reported results for its first quarter ended March 30, 2024.

Key Points: 
  • SANTA ANA, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- Ducommun Incorporated (NYSE: DCO) (“Ducommun” or the “Company”) today reported results for its first quarter ended March 30, 2024.
  • Interest expense for the first quarter of 2024 was $3.9 million compared to $4.2 million in the comparable period of 2023.
  • Electronic Systems segment net revenue for the quarter ended March 30, 2024 was $107.5 million, compared to $105.6 million for the first quarter of 2023.
  • Structural Systems segment net revenue for the quarter ended March 30, 2024 was $83.3 million, compared to $75.6 million for the first quarter of 2023.

TrainingToday recognized in Capterra's Shortlist report

Retrieved on: 
Lunedì, Aprile 15, 2024

BRENTWOOD, Tenn., April 15, 2024 /PRNewswire-PRWeb/ -- The Capterra Shortlist report highlights products based on Capterra's proprietary algorithm which includes user ratings and popularity ranking. According to Capterra's Shortlist methodologies, the Shortlist reports represent the best and most comprehensive view of products' recent popularity and ratings.

Key Points: 
  • BLR's TrainingToday was recognized in Capterra's Shortlist report for learning management system software released in January 2024.
  • TrainingToday earned this recognition because of its high user ratings and search popularity on the Capterra platform over the last two years.
  • BRENTWOOD, Tenn., April 15, 2024 /PRNewswire-PRWeb/ -- The Capterra Shortlist report highlights products based on Capterra's proprietary algorithm which includes user ratings and popularity ranking.
  • According to Capterra's Shortlist methodologies, the Shortlist reports represent the best and most comprehensive view of products' recent popularity and ratings.

FDA Grants Orphan Drug Designation for the Treatment of Scleroderma

Retrieved on: 
Giovedì, Aprile 11, 2024

NORTH CHICAGO, Ill., April 11, 2024 /PRNewswire/ -- BLR Bio, an emerging biotechnology company in Rosalind Franklin University's Helix 51 biomedical incubator , announced that the U.S. Food and Drug Administration (FDA) granted an Orphan Drug Designation for its investigational therapy BLR-200 for the treatment of systemic sclerosis (SSc), also known as scleroderma.

Key Points: 
  • NORTH CHICAGO, Ill., April 11, 2024 /PRNewswire/ -- BLR Bio, an emerging biotechnology company in Rosalind Franklin University's Helix 51 biomedical incubator , announced that the U.S. Food and Drug Administration (FDA) granted an Orphan Drug Designation for its investigational therapy BLR-200 for the treatment of systemic sclerosis (SSc), also known as scleroderma.
  • Orphan Drug Designation is granted by the FDA to investigational therapies addressing rare medical diseases or conditions that affect fewer than 200,000 people in the U.S.
  • "The FDA's granting of Orphan Drug Designation to BLR-200 highlights the urgent need for new and innovative therapeutic options for patients afflicted with the disease."
  • Dr. Ronald Kaplan, RFU executive vice president for research, said the orphan designation represents an important milestone in the development of BLR Bio's drug candidate.

Promising New Data Published on Potential Therapy to Boost Effectiveness of Pancreatic Cancer Treatments

Retrieved on: 
Martedì, Marzo 26, 2024

The data points to a promising strategy to boost the effectiveness of existing drugs in pancreatic cancer and other solid-tumor cancers.

Key Points: 
  • The data points to a promising strategy to boost the effectiveness of existing drugs in pancreatic cancer and other solid-tumor cancers.
  • According to the American Cancer Society , some 66,000 persons in the U.S. are diagnosed annually with pancreatic cancer, a disease with a very low survival rate that is projected to take 51,000 lives in 2024.
  • "Finding an approach to use lower doses while maintaining efficacy has been a constant search for cancer treatments."
  • "BLR-100 targets the formation of the protective tumor stroma, a fibrotic-like element that is thought to retard the entry of chemo-therapeutic agents."

BLR Wins Bronze for Best Advance in Learning Management Technology for Compliance Training from the Brandon Hall Group

Retrieved on: 
Martedì, Febbraio 27, 2024

BRENTWOOD, Tenn., Feb. 27, 2024 /PRNewswire-PRWeb/ -- BLR® has been a leader in the employee training industry for over five decades and is frequently recognized for expert content and service in the industry. This year, BLR is taking home a bronze medal in Brandon Hall Group's "Best Advance in Learning Management Technology for Compliance Training Category."

Key Points: 
  • BLR® was recognized for innovation in compliance training by the Brandon Hall Group Excellence in Technology Awards.
  • This year, BLR is taking home a bronze medal in Brandon Hall Group's "Best Advance in Learning Management Technology for Compliance Training Category."
  • TrainingToday® is an eLearning product of BLR that offers training content in a wide range of categories, along with a learning management system (LMS) that scales with businesses.
  • The Brandon Hall Group Excellence Awards recognize training solutions that provide innovative technology for learning, talent management, and development.

Ducommun Incorporated Reports Fourth Quarter 2023 Results

Retrieved on: 
Giovedì, Febbraio 15, 2024

SANTA ANA, Calif., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Ducommun Incorporated (NYSE: DCO) (“Ducommun” or the “Company”) today reported results for its fourth quarter and year ended December 31, 2023.

Key Points: 
  • New All Time Highs for Revenue and Adjusted EBITDA in 2023 of $757 Million and $102 Million, Respectively
    SANTA ANA, Calif., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Ducommun Incorporated (NYSE: DCO) (“Ducommun” or the “Company”) today reported results for its fourth quarter and year ended December 31, 2023.
  • The Company had a record year in 2023 and 2024 is shaping up to be another strong year as Ducommun also celebrates its 175th continuous year in business since being founded in 1849.”
    Net revenue for the fourth quarter of 2023 was $192.2 million, compared to $188.3 million for the fourth quarter of 2022.
  • Net income for the fourth quarter of 2023 was $5.1 million, or $0.34 per diluted share, compared to $8.1 million, or $0.65 per diluted share, for the fourth quarter of 2022.
  • During the fourth quarter of 2023, the net cash provided by operations was $26.5 million compared to $32.1 million during the fourth quarter of 2022.

Ducommun Incorporated Reports Third Quarter 2023 Results

Retrieved on: 
Mercoledì, Novembre 8, 2023

SANTA ANA, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Ducommun Incorporated (NYSE: DCO) (“Ducommun” or the “Company”) today reported results for its third quarter ended September 30, 2023.

Key Points: 
  • All-Time Record Quarterly Revenue and Adjusted Operating Income; Growth in both Commercial Aerospace and Defense; Strong Margin Expansion Driving Adjusted EBITDA to 14.9%
    SANTA ANA, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Ducommun Incorporated (NYSE: DCO) (“Ducommun” or the “Company”) today reported results for its third quarter ended September 30, 2023.
  • In summary, Ducommun is well positioned to execute our stated strategy over the next four years with significant runway ahead.”
    Net revenue for the third quarter of 2023 was $196.3 million compared to $186.6 million for the third quarter of 2022.
  • Electronic Systems segment net revenue for the quarter ended September 30, 2023 was $110.7 million, compared to $113.4 million for the third quarter of 2022.
  • Structural Systems segment net revenue for the quarter ended September 30, 2023 was $85.5 million, compared to $73.2 million for the third quarter of 2022.

BLR's EHS Daily Advisor honors the winners of the 2023 Safety Standout Awards for their dedication to safety and performance.

Retrieved on: 
Giovedì, Agosto 24, 2023

BRENTWOOD, Tenn., Aug. 24, 2023 /PRNewswire-PRWeb/ -- On August 21, 2023, during its EHS NOW virtual ceremony, BLR's EHS Daily Advisor extended congratulations to the winners of its annual Safety Standout Awards program for demonstrating steadfast commitment to workplace safety and compliance.

Key Points: 
  • On August 21, 2023, during its EHS NOW virtual ceremony, BLR's EHS Daily Advisor extended congratulations to the winners of its annual Safety Standout Awards program for demonstrating steadfast commitment to workplace safety and compliance.
  • BRENTWOOD, Tenn., Aug. 24, 2023 /PRNewswire-PRWeb/ -- On August 21, 2023, during its EHS NOW virtual ceremony, BLR's EHS Daily Advisor extended congratulations to the winners of its annual Safety Standout Awards program for demonstrating steadfast commitment to workplace safety and compliance.
  • Safety Standout Awards are given in the following six categories:
    Best Overall Safety Program and Culture: AT&T Field Operations
    AT&T Field Operations (AFO) created a national Environmental, Health, and Safety (EH&S) team focused on the EH&S concerns of its employees.
  • They deployed safety advocates and champions across the country to solely focus on safety conversations, best practices, and self-awareness.

Ducommun Incorporated Reports Second Quarter 2023 Results

Retrieved on: 
Giovedì, Agosto 3, 2023

SANTA ANA, Calif., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Ducommun Incorporated (NYSE: DCO) (“Ducommun” or the “Company”) today reported results for its second quarter ended July 1, 2023.

Key Points: 
  • SANTA ANA, Calif., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Ducommun Incorporated (NYSE: DCO) (“Ducommun” or the “Company”) today reported results for its second quarter ended July 1, 2023.
  • Net income for the second quarter of 2023 was $2.4 million, or $0.17 per diluted share, compared to $4.1 million, or $0.34 per diluted share, for the second quarter of 2022.
  • Gross profit for the second quarter of 2023 was $40.1 million, or 21.4% of revenue, compared to gross profit of $34.6 million, or 19.9% of revenue, for the second quarter of 2022.
  • During the second quarter of 2023, the net cash provided by operations was $9.2 million compared to $25.0 million during the second quarter of 2022.

BLR's HR Hero unveils expanded topic coverage to support the growing number of state-specific employment law enactments.

Retrieved on: 
Venerdì, Luglio 28, 2023

BRENTWOOD, Tenn., July 28, 2023 /PRNewswire-PRWeb/ -- Business & Learning Resources (BLR), a leading provider of business training and compliance solutions, is pleased to announce the expansion of topic areas covered in its flagship HR product, HR Hero®. Effective June 2023, HR Hero will include additional topics to provide more comprehensive decision support to its HR and PEO subscribers.

Key Points: 
  • BLR's HR Hero® expands its topic coverage to include voting leave and reimbursements in response to the growing number of state regulations in these areas.
  • Effective June 2023, HR Hero will include additional topics to provide more comprehensive decision support to its HR and PEO subscribers.
  • In addition to the new topics, HR Hero expanded coverage of existing areas, including retirement savings, pension plans, the FLSA, deductions in pay, and paychecks.
  • The new topics and expanded coverage within HR Hero provide clear summaries and in-depth analyses of employment law requirements through the Federal and State Topic Analysis tool.